Applied Therapeutics, Inc. — Director's Dealing 2024

Mar 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2024-03-14

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-14	Common Stock	S	318573.0000	$5.3900	Disposed	3817814.0000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1750000.0000	Indirect
Common Stock	1492094.0000	Indirect
Common Stock	709720.0000	Indirect
Common Stock	290280.0000	Indirect
Common Stock	88397.0000	Indirect

Footnotes

F1: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.

F2: Weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $5.37 to $5.795, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F3: Through a grantor retained annuity trust.

F4: Through a family trust controlled by the reporting person's spouse.

F5: Through the reporting person's spouse.

F6: Through a family trust controlled by the reporting person.

F7: Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.